relationship between TNF-alpha driven inflammation, lipids, and endothelial function in rheumatoid arthritis: a complex puzzle continues.

Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients. This editorial refers to 'TNF induces endothelial dysfunction in rheumatoid arthritis via LOX-1 and arginase 2: reversal by monoclonal TNF antibodies' by A. Akhmedov I et al. i , pp. 254-266. [Extracted from the article]